封面
市场调查报告书
商品编码
1698078

羊膜产品市场 - 全球产业规模、份额、趋势、机会和预测,按类型、应用、最终用户、地区和竞争细分,2020-2030 年预测

Amniotic Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End-User, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球羊膜产品市场价值为 8.5123 亿美元,预计在预测期内将达到 13.1777 亿美元,到 2030 年的复合年增长率为 7.53%。全球羊膜产品市场正在稳步扩张,这得益于对再生疗法、先进伤口护理解决方案和创新外科应用的需求不断增长。人们越来越意识到羊膜和相关产品在加速组织修復、减少发炎和减少疤痕方面的临床益处,这推动了其成长。加工和保存技术的技术创新带来了更高品质和更多功能的新产品,从而扩大了它们在骨科、眼科和整形外科领域的应用。研发投入的增加导致了具有更高功效和安全性的新型製剂的出现。市场正在见证医疗保健提供者对羊膜产品的日益认可,他们认识到羊膜产品在改善各个治疗领域患者治疗效果的潜力。

市场概览
预测期 2026-2030
2024 年市场规模 8.5123亿美元
2030年市场规模 13.1777亿美元
2025-2030 年复合年增长率 7.53%
成长最快的领域 冷冻保存的羊膜
最大的市场 北美洲

市场趋势表明,人们注重产品创新和策略合作伙伴关係,以扩大羊膜产品的临床应用。目前,人们正明显转向开发联合疗法,将这些生物製剂与其他治疗方式结合起来,以解决复杂的医疗状况。临床试验和科学研究正在强化羊膜产品的治疗价值,其在先进的伤口护理管理和再生医学中得到了充分利用。生物材料和组织工程的不断发展为下一代产品铺平了道路,带来了机会。生物技术公司、研究机构和医疗保健提供者之间的合作努力正在为产品开发和市场渗透创造新的途径。

主要市场驱动因素

再生医学需求不断成长

主要市场挑战

监管障碍和合规问题

来自捐赠组织的羊膜产品的自然变异性可能对保持一致的品质和满足监管标准带来挑战。

主要市场趋势

冷冻保存羊膜产品的采用率不断提高

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:全球羊膜产品市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依类型(冷冻保存羊膜、脱水羊膜)
    • 按应用(伤口护理、骨科、眼科、其他)
    • 按最终使用者(医院和门诊手术中心,其他)
    • 按地区
    • 按公司分类(2024)
  • 市场地图

第六章:北美羊膜产品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 加拿大
    • 墨西哥

第七章:欧洲羊膜产品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章:亚太地区羊膜产品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美洲羊膜产品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲羊膜产品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动因素与挑战

第 12 章:市场趋势与发展

  • 最新动态
  • 产品发布
  • 合併与收购

第 13 章:全球羊膜产品市场:SWOT 分析

第 14 章:竞争格局

  • MiMedx Group, Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Holdings, Inc.
  • Amnio technology LLC
  • Alliqua Biomedical, Inc.
  • Human Regenerative Technologies, LLC
  • Corza Ophthalmology Inc.
  • BioTissue Holdings, Inc.
  • Applied Biologics LLC

第 15 章:策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 17422

Global Amniotic Products Market was valued at USD 851.23 Million in 2024 and is expected to reach USD 1317.77 Million in the forecast period with a CAGR of 7.53% through 2030. The Global Amniotic Products Market is experiencing steady expansion driven by rising demand for regenerative therapies, advanced wound care solutions, and innovative surgical applications. Growth is fueled by an increasing awareness of the clinical benefits of amniotic membrane and related products in accelerating tissue repair, reducing inflammation, and minimizing scarring. Technological innovations in processing and preservation techniques have resulted in higher quality and more versatile products, thereby broadening their application in orthopedics, ophthalmology, and plastic surgery. Increased investments in research and development have led to the emergence of novel formulations that offer enhanced efficacy and safety profiles. The market is witnessing growing acceptance among healthcare providers who recognize the potential of amniotic products to improve patient outcomes in various therapeutic areas.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 851.23 Million
Market Size 2030USD 1317.77 Million
CAGR 2025-20307.53%
Fastest Growing SegmentCryopreserved Amniotic Membranes
Largest MarketNorth America

Trends in the market reveal a focus on product innovation and strategic partnerships to expand the clinical applications of amniotic products. There is a notable shift toward developing combination therapies that integrate these biologics with other treatment modalities to address complex medical conditions. Clinical trials and scientific studies are reinforcing the therapeutic value of amniotic membrane products, which are being leveraged in advanced wound care management and regenerative medicine. Opportunities arise from the ongoing evolution in biomaterials and tissue engineering, which are paving the way for next-generation products. Collaborative efforts among biotechnology firms, research institutions, and healthcare providers are creating new avenues for product development and market penetration.

Key Market Drivers

Increasing Demand for Regenerative Medicine

The field of regenerative medicine has witnessed a remarkable surge in interest and demand, and this wave of enthusiasm has not bypassed the Global Amniotic Products Market. Regenerative medicine is a multidisciplinary approach that seeks to restore or enhance the body's natural ability to heal and regenerate damaged tissues. The primary reasons behind the escalating demand for regenerative medicine is its patient-centric approach. Patients today are increasingly seeking treatments that not only alleviate symptoms but also address the root causes of their medical conditions. Regenerative therapies, including amniotic products, have emerged as a promising avenue in this regard. They offer the potential for long-term healing and restoration of function, rather than just short-term relief. According to the U.S. National Institutes of Health (NIH), funding for regenerative medicine research increased by 15% from 2022 to 2023, reaching nearly USD 2.8 billion, which underscores the growing investment in this field.

Key Market Challenges

Regulatory Hurdles and Compliance Issues

One of the foremost challenges facing the Amniotic Products Market is the complex regulatory landscape governing the use of these products. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have stringent requirements for product safety, efficacy, and labeling. Compliance with these regulations demands substantial resources, time, and expertise.

Amniotic products are categorized as biological drugs or medical devices, subjecting them to rigorous testing and approval processes. Meeting the requirements for clinical trials and pre-market approval can be time-consuming and costly. The regulatory landscape for regenerative therapies is continually evolving. Changes in regulations and guidelines can lead to uncertainty for manufacturers and potentially impact market access.

The natural variability of amniotic products derived from donor tissues can pose challenges in maintaining consistent quality and meeting regulatory standards.

Key Market Trends

Increasing Adoption of Cryopreserved Amniotic Products

One prominent trend in the Global Amniotic Products Market is the increasing adoption of cryopreserved amniotic products. Cryopreservation involves the freezing and long-term storage of amniotic tissues while preserving their biological activity. This method offers several advantages:

Cryopreservation significantly extends the shelf life of amniotic products, allowing for easier distribution and use in various healthcare settings. Cryopreserved amniotic products retain their biological properties, such as growth factors and cytokines, ensuring that they remain efficacious when used in clinical applications. Healthcare providers can access cryopreserved amniotic products as needed, reducing the need for fresh tissue procurement and processing, which can be time-consuming.

Key Market Players

  • MiMedx Group, Inc.
  • Integra LifeSciences Holdings Corporation
  • Organogenesis Holdings, Inc.
  • Amnio technology LLC
  • Alliqua Biomedical, Inc.
  • Human Regenerative Technologies, LLC
  • Corza Ophthalmology Inc.
  • BioTissue Holdings, Inc.
  • Applied Biologics LLC

Report Scope:

In this report, the Global Amniotic Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Amniotic Products Market, By Type:

  • Cryopreserved Amniotic Membranes
  • Dehydrated Amniotic Membranes

Amniotic Products Market, By Application:

  • Wound Care
  • Orthopedics
  • Ophthalmology
  • Others

Amniotic Products Market, By End-User:

  • Hospitals & Ambulatory Surgical Centers
  • Other

Amniotic Products Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Amniotic Products Market.

Available Customizations:

Global Amniotic Products market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Amniotic Products Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes)
    • 5.2.2. By Application (Wound Care, Orthopedics, Ophthalmology, Others)
    • 5.2.3. By End-User (Hospitals & Ambulatory Surgical Centers, Other)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Amniotic Products Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End-User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Amniotic Products Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-User
    • 6.3.2. Canada Amniotic Products Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-User
    • 6.3.3. Mexico Amniotic Products Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-User

7. Europe Amniotic Products Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End-User
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Amniotic Products Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-User
    • 7.3.2. United Kingdom Amniotic Products Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-User
    • 7.3.3. Italy Amniotic Products Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-User
    • 7.3.4. France Amniotic Products Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-User
    • 7.3.5. Spain Amniotic Products Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-User

8. Asia-Pacific Amniotic Products Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Amniotic Products Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-User
    • 8.3.2. India Amniotic Products Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-User
    • 8.3.3. Japan Amniotic Products Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-User
    • 8.3.4. South Korea Amniotic Products Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-User
    • 8.3.5. Australia Amniotic Products Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-User

9. South America Amniotic Products Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End-User
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Amniotic Products Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-User
    • 9.3.2. Argentina Amniotic Products Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-User
    • 9.3.3. Colombia Amniotic Products Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-User

10. Middle East and Africa Amniotic Products Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End-User
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Amniotic Products Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-User
    • 10.3.2. Saudi Arabia Amniotic Products Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-User
    • 10.3.3. UAE Amniotic Products Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-User

11. Market Dynamics

  • 11.1. Drivers & Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Amniotic Products Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. MiMedx Group, Inc.
  • 14.2. Integra LifeSciences Holdings Corporation
  • 14.3. Organogenesis Holdings, Inc.
  • 14.4. Amnio technology LLC
  • 14.5. Alliqua Biomedical, Inc.
  • 14.6. Human Regenerative Technologies, LLC
  • 14.7. Corza Ophthalmology Inc.
  • 14.8. BioTissue Holdings, Inc.
  • 14.9. Applied Biologics LLC

15. Strategic Recommendations

16. About Us & Disclaimer